Literature DB >> 23612118

Functional integrity of the T-tubular system in cardiomyocytes depends on p21-activated kinase 1.

Jaime DeSantiago1, Dan J Bare, Yunbo Ke, Katherine A Sheehan, R John Solaro, Kathrin Banach.   

Abstract

p21-activated kinase (Pak1), a serine-threonine protein kinase, regulates cytoskeletal dynamics and cell motility. Recent experiments further demonstrate that loss of Pak1 results in exaggerated hypertrophic growth in response to pathophysiological stimuli. Calcium (Ca) signaling plays an important role in the regulation of transcription factors involved in hypertrophic remodeling. Here we aimed to determine the role of Pak1 in cardiac excitation-contraction coupling (ECC). Ca transients were recorded in isolated, ventricular myocytes (VMs) from WT and Pak1(-/-) mice. Pak1(-/-) Ca transients had a decreased amplitude, prolonged rise time and delayed recovery time. Di-8-ANNEPS staining revealed a decreased T-tubular density in Pak1(-/-) VMs that coincided with decreased cell capacitance and increased dis-synchrony of Ca induced Ca release (CICR) at individual release units. These changes were not observed in atrial myocytes of Pak1(-/-) mice where the T-tubular system is only sparsely developed. Experiments in cultured rabbit VMs supported a role of Pak1 in the maintenance of the T-tubular structure. T-tubular density in rabbit VMs significantly decreased within 24h of culture. This was accompanied by a decrease of the Ca transient amplitude and a prolongation of its rise time. However, overexpression of constitutively active Pak1 in VMs attenuated the structural remodeling as well as changes in ECC. The results provide significant support for a prominent role of Pak1 activity not only in the functional regulation of ECC but for the structural maintenance of the T-tubular system whose remodeling is an integral feature of hypertrophic remodeling.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23612118      PMCID: PMC3679655          DOI: 10.1016/j.yjmcc.2013.04.014

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  58 in total

Review 1.  p21-activated kinases: three more join the Pak.

Authors:  Zahara M Jaffer; Jonathan Chernoff
Journal:  Int J Biochem Cell Biol       Date:  2002-07       Impact factor: 5.085

2.  Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics.

Authors:  D C Edwards; L C Sanders; G M Bokoch; G N Gill
Journal:  Nat Cell Biol       Date:  1999-09       Impact factor: 28.824

3.  Spatial and temporal inhomogeneities during Ca2+ release from the sarcoplasmic reticulum in pig ventricular myocytes.

Authors:  Frank R Heinzel; Virginie Bito; Paul G A Volders; Gudrun Antoons; Kanigula Mubagwa; Karin R Sipido
Journal:  Circ Res       Date:  2002-11-29       Impact factor: 17.367

4.  Sildenafil prevents and reverses transverse-tubule remodeling and Ca(2+) handling dysfunction in right ventricle failure induced by pulmonary artery hypertension.

Authors:  Yu-Ping Xie; Biyi Chen; Philip Sanders; Ang Guo; Yue Li; Kathy Zimmerman; Lie-Cheng Wang; Robert M Weiss; Isabella M Grumbach; Mark E Anderson; Long-Sheng Song
Journal:  Hypertension       Date:  2011-12-27       Impact factor: 10.190

5.  p21-activated kinase improves cardiac contractility during ischemia-reperfusion concomitant with changes in troponin-T and myosin light chain 2 phosphorylation.

Authors:  Michelle M Monasky; Domenico M Taglieri; Bindiya G Patel; Jonathan Chernoff; Beata M Wolska; Yunbo Ke; R John Solaro
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-10-28       Impact factor: 4.733

6.  Effects of PP1/PP2A inhibitor calyculin A on the E-C coupling cascade in murine ventricular myocytes.

Authors:  William H duBell; Marisa S Gigena; Silvia Guatimosim; Xilin Long; W J Lederer; Terry B Rogers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-01       Impact factor: 4.733

Review 7.  Regulation of cardiac excitation and contraction by p21 activated kinase-1.

Authors:  Yunbo Ke; Ming Lei; R John Solaro
Journal:  Prog Biophys Mol Biol       Date:  2009-01-24       Impact factor: 3.667

8.  Amphiphysin 2 (Bin1) and T-tubule biogenesis in muscle.

Authors:  Eunkyung Lee; Melissa Marcucci; Laurie Daniell; Marc Pypaert; Ora A Weisz; Gian-Carlo Ochoa; Khashayar Farsad; Markus R Wenk; Pietro De Camilli
Journal:  Science       Date:  2002-08-16       Impact factor: 47.728

9.  Pak1 as a novel therapeutic target for antihypertrophic treatment in the heart.

Authors:  Wei Liu; Min Zi; Ronald Naumann; Susanne Ulm; Jiawei Jin; Domenico M Taglieri; Sukhpal Prehar; Junhong Gui; Hoyee Tsui; Rui-Ping Xiao; Ludwig Neyses; R John Solaro; Yunbo Ke; Elizabeth J Cartwright; Ming Lei; Xin Wang
Journal:  Circulation       Date:  2011-11-14       Impact factor: 29.690

10.  Ablation of p21-activated kinase-1 in mice promotes isoproterenol-induced cardiac hypertrophy in association with activation of Erk1/2 and inhibition of protein phosphatase 2A.

Authors:  Domenico M Taglieri; Michelle M Monasky; Ivana Knezevic; Katherine A Sheehan; Ming Lei; Xin Wang; Jonathan Chernoff; Beata M Wolska; Yunbo Ke; R John Solaro
Journal:  J Mol Cell Cardiol       Date:  2011-09-24       Impact factor: 5.000

View more
  11 in total

1.  Loss of p21-activated kinase 1 (Pak1) promotes atrial arrhythmic activity.

Authors:  Jaime DeSantiago; Dan J Bare; Disha Varma; R John Solaro; Rishi Arora; Kathrin Banach
Journal:  Heart Rhythm       Date:  2018-04-03       Impact factor: 6.343

2.  Sheet-Like Remodeling of the Transverse Tubular System in Human Heart Failure Impairs Excitation-Contraction Coupling and Functional Recovery by Mechanical Unloading.

Authors:  Thomas Seidel; Sutip Navankasattusas; Azmi Ahmad; Nikolaos A Diakos; Weining David Xu; Martin Tristani-Firouzi; Michael J Bonios; Iosif Taleb; Dean Y Li; Craig H Selzman; Stavros G Drakos; Frank B Sachse
Journal:  Circulation       Date:  2017-01-10       Impact factor: 29.690

Review 3.  P21-activated kinase in inflammatory and cardiovascular disease.

Authors:  Domenico M Taglieri; Masuko Ushio-Fukai; Michelle M Monasky
Journal:  Cell Signal       Date:  2014-05-02       Impact factor: 4.315

4.  p21-Activated kinase1 (Pak1) is a negative regulator of NADPH-oxidase 2 in ventricular myocytes.

Authors:  Jaime DeSantiago; Dan J Bare; Lei Xiao; Yunbo Ke; R John Solaro; Kathrin Banach
Journal:  J Mol Cell Cardiol       Date:  2013-12-28       Impact factor: 5.000

Review 5.  Murine Electrophysiological Models of Cardiac Arrhythmogenesis.

Authors:  Christopher L-H Huang
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

Review 6.  The p21-activated kinase 1 (Pak1) signalling pathway in cardiac disease: from mechanistic study to therapeutic exploration.

Authors:  Yanwen Wang; Shunyao Wang; Ming Lei; Mark Boyett; Hoyee Tsui; Wei Liu; Xin Wang
Journal:  Br J Pharmacol       Date:  2017-06-28       Impact factor: 8.739

Review 7.  PAK1 is a novel cardiac protective signaling molecule.

Authors:  Yunbo Ke; Xin Wang; Xu Yu Jin; R John Solaro; Ming Lei
Journal:  Front Med       Date:  2014-11-22       Impact factor: 4.592

Review 8.  Novel insights into mechanisms for Pak1-mediated regulation of cardiac Ca(2+) homeostasis.

Authors:  Yanwen Wang; Hoyee Tsui; Emma L Bolton; Xin Wang; Christopher L-H Huang; R John Solaro; Yunbo Ke; Ming Lei
Journal:  Front Physiol       Date:  2015-03-17       Impact factor: 4.566

9.  Pak1 is required to maintain ventricular Ca²⁺ homeostasis and electrophysiological stability through SERCA2a regulation in mice.

Authors:  Yanwen Wang; Hoyee Tsui; Yunbo Ke; Ying Shi; Yatong Li; Laura Davies; Elizabeth J Cartwright; Luigi Venetucci; Henggui Zhang; Derek A Terrar; Christopher L-H Huang; R John Solaro; Xin Wang; Ming Lei
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-09-12

Review 10.  Unique catalytic activities and scaffolding of p21 activated kinase-1 in cardiovascular signaling.

Authors:  Yunbo Ke; Ming Lei; Xin Wang; R John Solaro
Journal:  Front Pharmacol       Date:  2013-09-27       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.